Mode of action of L-DOPA on central noradrenaline mechanisms.
D000818:Animals; D001794:Blood Pressure; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000187:drug effects; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013116:Spinal Cord / Q000032:analysis; D013268:Stimulation, Chemical; D013859:Thiocarbamates / Q000494:pharmacology
D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013859:Thiocarbamates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine